NF-kB inhibitor blocks B cell development at two checkpoints.
NF-kB inhibitor blocks B cell development at two checkpoints.
复制标题
DOI:
10.1186/1476-9433-3-1
复制
发表时间:
2004-03-29
期刊:
影响因子:
--
通讯作者:
Liou, Hsiou-Chi
中科院分区:
文献类型:
--
作者:
Feng, Biao;Cheng, Shuhua;Liou, Hsiou-Chi
Members of the NF-kB transcription factor family are differentially expressed in the B cell lineage. Disruption of individual or two NF-kB subunits exhibits distinct defects in B lymphocyte development, activation, and survival. However, the role each NF-kB plays during B cell development has been obscured by molecular compensation. To address this issue, a trans-dominant form of IkBalpha was transduced into bone marrow cells to act as a pan-inhibitor of NF-kB using a retroviral system. While the development of T-lymphocytes and myeloid cell lineages was not grossly affected by the transduced IkBalpha gene, a significant reduction in the number and percentage of B lineage cells was apparent in IkBalpha transduced chimeric mice. IkBalpha expression decreased the percentage of pre-B and immature B cell subsets in the bone marrow and further impaired the development of follicular mature B cells and marginal zone B cells in the periphery. Introduction of the Bcl-X transgene completely restored the pre-B and immature B cell pool in the bone marrow. However, despite a significant improvement of overall viability of the B cell lineage, Bcl-X expression was insufficient to overcome the maturation block resulting from NF-kB inhibition. Together, our study suggests that NF-kB activity is required for two distinct checkpoints during B cell development: one is for pre-B/immature B cell viability, the other is to provide both survival and maturation signals to ensure the proper development of follicular mature B cells.